Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study

References

• Johnson RW. Herpes zoster and postherpetic neuralgia. Expert Rev Vaccines 2010; 9(3 Suppl):21-6; PMID:20192714; http://dx.doi.org/10.1586/erv.10.30
   PubMed Web of Science ®Google Scholar
• Cohen JI. Clinical practice: Herpes zoster. N Engl J Med 2013; 369(3):255-63; PMID:23863052; http://dx.doi.org/10.1056/NEJMcp1302674
   PubMed Web of Science ®Google Scholar
• Kawai K, Gebremeskel BG, Acosta CJ. Systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 2014; 4:e004833; PMID:24916088; http://dx.doi.org/10.1136/bmjopen-2014-004833
   PubMed Web of Science ®Google Scholar
• Miller E, Marshall R, Vurdien J. Epidemiology, outcome and control of varicella-zoster infection. Rev Med Microbiol 1993; 4:222-30; http://dx.doi.org/10.1097/00013542-199310000-00006
   Google Scholar
• Schmader K. Herpes zoster in older adults. Clin Infect Dis 2001; 32:1481-6; PMID:11317250; http://dx.doi.org/10.1086/320169
   PubMed Web of Science ®Google Scholar
• Schmader K, Gnann JW Jr, Watson CP. The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis 2008; 197:S207-15; PMID:18419399; http://dx.doi.org/10.1086/522152
   PubMed Web of Science ®Google Scholar
• Johnson RW, Bouhassira D, Kassianos G, Leplège A, Schmader KE, Weinke T. The impact of herpes zoster and post-herpetic neuralgia on quality-of-life. BMC Med 2010; 8:37; PMID:20565946; http://dx.doi.org/10.1186/1741-7015-8-37
   PubMed Web of Science ®Google Scholar
• Whitley RJ, Shukla S, Crooks RJ. The identification of risk factors associated with persistent pain following Herpes Zoster. J Infect Dis 1998; 178:S71-5; PMID:9852979; http://dx.doi.org/10.1086/514274
   PubMed Web of Science ®Google Scholar
• Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology 2004; 62:1545-51; PMID:15136679; http://dx.doi.org/10.1212/01.WNL.0000123261.00004.29
   PubMed Web of Science ®Google Scholar
• Gabutti G, Valente N, Sulcaj N, Stefanati A. Evaluation of efficacy and effectiveness of live attenuated zoster vaccine. J Prev Med Hyg 2014; 55:130-6; PMID:26137786
   PubMedGoogle Scholar
• Volpi A. Severe complications of herpes zoster. Herpes 2007; 14(Suppl 2):35-9.
   PubMedGoogle Scholar
• Di Luzio Paparatti U, Arpinelli F, Visona G. Herpes zoster and its complications in Italy: an observational survey. J Infect 1999; 38:116-119; PMID:10342652; http://dx.doi.org/10.1016/S0163-4453(99)90079-8
   PubMed Web of Science ®Google Scholar
• Di Legami V, Gianino MM, Atti MCD, Massari M, Migliardi A, Tomba GS, Zotti C, Zoster Study Group. Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine 2007; 25:7598-7604; PMID:17889410; http://dx.doi.org/10.1016/j.vaccine.2007.07.049
   PubMed Web of Science ®Google Scholar
• Gialloreti LE, Merito M, Pezzotti P, Naldi L, Gatti A, Beillat M, Serradell L, di Marzo R, Volpi A. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 2010; 10:230; PMID:20682044; http://dx.doi.org/10.1186/1471-2334-10-230
   PubMed Web of Science ®Google Scholar
• Takao Y, Miyazaki Y, Okeda M, Onishi F, Yano S, Gomi Y, Ishikawa T, Okuno Y, Mori Y, Asada H, et al. Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese adults aged 50 years and older from a community-based prospective cohort study: The SHEZ study. J Epidemiol 2015; 25:617-25; PMID:26399445; http://dx.doi.org/10.2188/jea.JE20140210
   PubMed Web of Science ®Google Scholar
• Fleming DM, Cross KW, Cobb WA, Chapman RS. Gender difference in the incidence of shingles. Epidemiol Infect 2004; 132:1-5; PMID:14979582; http://dx.doi.org/10.1017/S0950268803001523
   PubMed Web of Science ®Google Scholar
• Johnson BH, Palmer L, Gatwood J, Lenhart G, Kawai K, Acosta CJ. Annual incidence rates of herpes zoster among an immunocompetent population in the United States. BMC Infect Dis 2015; 15:502; PMID:26546419; http://dx.doi.org/10.1186/s12879-015-1262-8
   PubMed Web of Science ®Google Scholar
• Kawai K, Rampakakis E, Tsai TF, Cheong HJ, Dhitavat J, Covarrubias AO, Yang L, Cashat-Cruz M, Monsanto H, Johnson K, et al. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia. Int J Infect Dis 2015; 34:126-31; PMID:25841633; http://dx.doi.org/10.1016/j.ijid.2015.03.022
   PubMed Web of Science ®Google Scholar
• Tran KD, Falcone MM, Choi DS, Goldhardt R, Karp CL, Davis JL, Galor A. Epidemiology of Herpes Zoster Ophthalmicus: Recurrence and chronicity. Ophthalmology 2016; 123:1469-75; PMID:27067924; http://dx.doi.org/10.1016/j.ophtha.2016.03.005
   PubMed Web of Science ®Google Scholar
• Yawn BP, Wollan PC, Kurland MJ, St Sauver JL, Saddier P. Herpes zoster recurrences more frequent than previously reported. Mayo Clin Proc 2011; 86:88-93; PMID:21220354; http://dx.doi.org/10.4065/mcp.2010.0618
   PubMed Web of Science ®Google Scholar
• Paganino C, Alicino C, Trucchi C, Albanese E, Sticchi L, Icardi G. Herpes Zoster: the rationale for the introduction of vaccination in Italy. J Prev Med Hyg 2015; 56:E33-6; PMID:26789830
   PubMedGoogle Scholar
• Ansaldi F, Trucchi C, Alicino C, Paganino C, Orsi A, Icardi G. Real-world effectiveness and safety of a live-attenuated herpes zoster vaccine: a comprehensive review. Adv Ther 2016; 33:1094-104; PMID:27262452; http://dx.doi.org/10.1007/s12325-016-0355-0
   PubMed Web of Science ®Google Scholar